Comparison Enliven Therapeutics (ELVN) with Competitors
Enliven Therapeutics (ELVN) industry is Biotechnology.
Free Cash Flow Yield
ELVN-2.60%
Industry-1.94%
Upside-0.65%
P/E
ELVN-25.02
Industry-18.88
Upside-614.44%
P/B
ELVN5.46
Industry4.70
Upside+16.23%